INHIBITION BY 5-IODODEOXYURIDINE OF THE ONCOGENIC EFFECTS OF ADENOVIRUS TYPE 12 IN HAMSTERS.
Subcutaneous tumors induced in newborn hamsters by type 12 adenovirus were suppressed when 0.5 mg of 5-iodo-2'-deoxyuridine (IUdR) was given at the same subcutaneous site as the virus. Although one injection of IUdR given immediately after the virus was effective, additional injections on subsequent days reduced further the number of hamsters developing tumors. These effects of lUdR are especially interesting since replication of infectious adenovirus 12 cannot be demonstrated in the hamsters at any time before or after tumor development.
D000256:Adenoviridae; D000257:Adenoviridae Infections; D000818:Animals; D000970:Antineoplastic Agents; D002273:Carcinogens; D006224:Cricetinae; D006801:Humans; D007065:Idoxuridine / Q000031:analogs & derivatives; D009369:Neoplasms; D010600:Pharmacology; D012106:Research; D014780:Viruses
D000970:Antineoplastic Agents; D002273:Carcinogens; C029954:5'-deoxy-5'-iodouridine; D007065:Idoxuridine
ADENOVIRUS; ANTINEOPLASTIC AGENTS; CARCINOGENS; EXPERIMENTAL LAB STUDY; HAMSTERS; IDOXURIDINE; PHARMACOLOGY